Literature DB >> 20354593

HIV-1 Transmission, Replication Fitness and Disease Progression.

Tasha Biesinger1, Jason T Kimata.   

Abstract

Upon transmission, human immunodeficiency virus type 1 (HIV-1) establishes infection of the lymphatic reservoir, leading to profound depletion of the memory CD4(+) T cell population, despite the induction of the adaptive immune response. The rapid evolution and association of viral variants having distinct characteristics with different stages of infection, the level of viral burden, and rate of disease progression suggest a role for viral variants in this process. Here, we review the literature on HIV-1 variants and disease and discuss the importance of viral fitness for transmission and disease.

Entities:  

Year:  2008        PMID: 20354593      PMCID: PMC2846839     

Source DB:  PubMed          Journal:  Virology (Auckl)        ISSN: 1178-122X


  223 in total

1.  Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication.

Authors:  R Wagner; B Leschonsky; E Harrer; C Paulus; C Weber; B D Walker; S Buchbinder; H Wolf; J R Kalden; T Harrer
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

2.  Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope.

Authors:  Fred W Peyerl; Heidi S Bazick; Michael H Newberg; Dan H Barouch; Joseph Sodroski; Norman L Letvin
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.

Authors:  Caroline S Fernandez; Miranda Z Smith; C Jane Batten; Robert De Rose; Jeanette C Reece; Erik Rollman; Vanessa Venturi; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

4.  Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.

Authors:  Mattias Mild; Joakim Esbjörnsson; Eva Maria Fenyö; Patrik Medstrand
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

5.  Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.

Authors:  V S Torre; A J Marozsan; J L Albright; K R Collins; O Hartley; R E Offord; M E Quiñones-Mateu; E J Arts
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.

Authors:  Paul J Peters; W Matthew Sullivan; Maria J Duenas-Decamp; Jayanta Bhattacharya; Chiambah Ankghuambom; Richard Brown; Katherine Luzuriaga; Jeanne Bell; Peter Simmonds; Jonathan Ball; Paul R Clapham
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 7.  HIV-1 envelope determinants for cell tropism and chemokine receptor use.

Authors:  T L Hoffman; R W Doms
Journal:  Mol Membr Biol       Date:  1999 Jan-Mar       Impact factor: 2.857

8.  Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry.

Authors:  Andre J Marozsan; Dawn M Moore; Michael A Lobritz; Erika Fraundorf; Awet Abraha; Jacqueline D Reeves; Eric J Arts
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.

Authors:  A Koito; G Harrowe; J A Levy; C Cheng-Mayer
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  5 in total

1.  Longitudinal Analysis of Cerebrospinal Fluid and Plasma HIV-1 Envelope Sequences Isolated From a Single Donor with HIV Asymptomatic Neurocognitive Impairment.

Authors:  Fabián Vázquez-Santiago; Yashira García; Ivelisse Rivera-Román; Richard J Noel; Valerie Wojna; Loyda M Meléndez; Vanessa Rivera-Amill
Journal:  J Virol Antivir Res       Date:  2015

2.  Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load.

Authors:  Lele Zhao; Chris Wymant; François Blanquart; Tanya Golubchik; Astrid Gall; Margreet Bakker; Daniela Bezemer; Matthew Hall; Swee Hoe Ong; Jan Albert; Norbert Bannert; Jacques Fellay; M Kate Grabowski; Barbara Gunsenheimer-Bartmeyer; Huldrych F Günthard; Pia Kivelä; Roger D Kouyos; Oliver Laeyendecker; Laurence Meyer; Kholoud Porter; Ard van Sighem; Marc van der Valk; Ben Berkhout; Paul Kellam; Marion Cornelissen; Peter Reiss; Christophe Fraser; Luca Ferretti
Journal:  Virus Evol       Date:  2022-03-16

3.  Amino Acid Deletions in p6Gag Domain of HIV-1 CRF07_BC Ameliorate Galectin-3 Mediated Enhancement in Viral Budding.

Authors:  Wen-Hung Wang; Chun-Sheng Yeh; Chih-Yen Lin; Ruei-Yu Yuan; Aspiro Nayim Urbina; Po-Liang Lu; Yen-Hsu Chen; Yi-Ming Arthur Chen; Fu-Tong Liu; Sheng-Fan Wang
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

4.  HIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscape.

Authors:  S Abigail Smith; Charles Wood; John T West
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

5.  Short-Term Dynamic and Local Epidemiological Trends in the South American HIV-1B Epidemic.

Authors:  Dennis Maletich Junqueira; Rubia Marília de Medeiros; Tiago Gräf; Sabrina Esteves de Matos Almeida
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.